High Mobility Group 20B (HMG20B) Peptid
HMG20B
Reaktivität: Human
Wirt: Synthetic
BP
-
- Target Alle HMG20B Produkte
- HMG20B (High Mobility Group 20B (HMG20B))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-BRAF35 Antibody reactivity.
-
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- HMG20B (High Mobility Group 20B (HMG20B))
- Hintergrund
- BRAF35, HMGX2, HMGXB2, SMARCE1R, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related, SMARCE1-related protein, BRCA2-associated factor 35, HMG box-containing protein 20B, HMG domain-containing protein 2, HMG domain-containing protein HMGX2, Sox-like transcriptional factor, Structural DNA-binding protein BRAF35
- Gen-ID
- 10362
- UniProt
- Q9P0W2
-
Sie sind hier:
